scorecardresearch
Friday, August 1, 2025
TopicAstraZeneca

Topic: AstraZeneca

India to give 60 of 140 patients for clinical trial of cancer drug Acalabrutinib for Covid

The drug, branded as Calquence by AstraZeneca, has improved clinical outcomes of patients with severe Covid-19, according to a peer-reviewed study.

AstraZeneca-Gilead deal might not actually happen, say analysts

Political opposition from both Britain and America could derail any attempt at a deal, especially given the backdrop of the Covid-19 outbreak.

Why AstraZeneca is pondering a $240 billion gamble with Gilead

Combining the science teams of two pharma giants ought to aid future drug discovery. But it's still not clear if either side needs this deal.

Big pharma is looking beyond coronavirus with AstraZeneca eyeing merger with Gilead

The suggestion of a blockbuster merger between the two drugmakers is a sign that the industry is getting back to something resembling business as usual.

AstraZeneca’s cancer drug shows early signs of promise in treating severe Covid cases

The results, published in Science Immunology, are promising enough for AstraZeneca to launch the second phase of the trial, which will involve 200 patients.

Why AstraZeneca needs to avoid getting sucked into ‘vaccine nationalism’

AstraZeneca is indicating it can meet orders for its Covid vaccine from various countries simultaneously. It’s a laudable aspiration that needs to be achieved.

On Camera

Trump tariff forces India to shed illusion. Stop conflating status with power

India’s future lies in pragmatism. Protectionism must be phased out gradually, not in disruptive shocks.

BJP MPs go full throttle against Trump even as govt hails enduring India-US ties amid tariff tension

New Delhi: While the Indian government has made a measured response to the 25 percent trade tariff imposed by Donald Trump, many in the BJP...

India to get last of Spain-built C-295 next month, focus now on 1st India-made aircraft

New Delhi: The last of the C-295 transport aircraft that is replacing the ageing Avro fleet of the Indian Air Force (IAF) will be...

Modi’s Bharat vs Indira’s India: 11-yr report card of politics, diplomacy, economy, nationalism

As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.